par Delaunoit, Thierry 
;Burch, Patrick A;Reid, Joel M;Camoriano, John K;Kobayash, Tomowo;Braich, Theodore A;Kaur, Judith S;Rubin, Joseph;Erlichman, Charles
Référence Investigational new drugs, 24, 4, page (327-333)
Publication Publié, 2006-07
;Burch, Patrick A;Reid, Joel M;Camoriano, John K;Kobayash, Tomowo;Braich, Theodore A;Kaur, Judith S;Rubin, Joseph;Erlichman, CharlesRéférence Investigational new drugs, 24, 4, page (327-333)
Publication Publié, 2006-07
Article révisé par les pairs
| Titre: |
|
| Auteur: | Delaunoit, Thierry; Burch, Patrick A; Reid, Joel M; Camoriano, John K; Kobayash, Tomowo; Braich, Theodore A; Kaur, Judith S; Rubin, Joseph; Erlichman, Charles |
| Informations sur la publication: | Investigational new drugs, 24, 4, page (327-333) |
| Statut de publication: | Publié, 2006-07 |
| Sujet CREF: | Cancérologie |
| MeSH keywords: | Administration, Oral |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Antineoplastic Agents -- adverse effects -- chemistry -- pharmacokinetics -- therapeutic use | |
| Arabinonucleosides -- adverse effects -- chemistry -- pharmacokinetics -- therapeutic use | |
| Cytosine -- adverse effects -- analogs & derivatives -- chemistry -- pharmacokinetics -- therapeutic use | |
| Dose-Response Relationship, Drug | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Staging | |
| Neoplasms -- drug therapy -- pathology | |
| Note générale: | Clinical Trial, Phase I |
| Journal Article | |
| Research Support, Non-U.S. Gov't | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0167-6997 |
| info:doi/10.1007/s10637-006-5392-0 | |
| info:pmid/16502355 |
